Search Results - "Seelhammer, Troy G"
-
1
Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation
Published in Critical care medicine (01-09-2021)“…To provide a comparative analysis of conventional heparin- versus bivalirudin-based systemic anticoagulation in adult and pediatric patients supported on…”
Get full text
Journal Article -
2
Extracorporeal Membrane Oxygenation in Acute Respiratory Failure
Published in Pulmonary therapy (01-03-2023)“…Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is a form of mechanical life support that provides full respiratory bypass in patients with severe…”
Get full text
Journal Article -
3
A Systematic Review of Preexisting Sepsis and Extracorporeal Membrane Oxygenation
Published in ASAIO journal (1992) (01-01-2020)“…We retrospectively reviewed all pertinent extracorporeal membrane oxygenation (ECMO) studies (January 1995 to September 2017) of adults with sepsis as a…”
Get full text
Journal Article -
4
Kinetic estimated glomerular filtration rate and acute kidney injury in cardiac surgery patients
Published in Journal of critical care (01-02-2016)“…Abstract Purpose To determine how a formula to estimate kinetically changing glomerular filtration rate (keGFR) relates to serum creatinine changes and to…”
Get full text
Journal Article -
5
Cardiac tamponade in a patient supported by veno-arterial extracorporeal membrane oxygenation
Published in Annals of cardiac anaesthesia (01-04-2022)“…Cardiac tamponade occurring in a patient supported on central veno-arterial extracorporeal membrane oxygenation is depicted in a transesophageal…”
Get full text
Journal Article -
6
Maintenance of Drug-eluting Stent Patency through Use of a Cangrelor Infusion in the Clinical Setting of Massive Pulmonary Hemorrhage and Venoarterial Extracorporeal Membrane Oxygenation
Published in Journal of cardiothoracic and vascular anesthesia (01-12-2017)“…We report ultra-short–acting parenteral P2Y12 inhibitor, cangrelor, for maintenance of fresh drug-eluting stent patency concurrent pulmonary hemorrhage and…”
Get full text
Journal Article -
7
Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
Published in Journal of cardiothoracic and vascular anesthesia (01-04-2021)“…In its severe manifestation, coronavirus disease 2019 (COVID-19) compromises oxygenation in a manner that is refractory to maximal conventional support and…”
Get full text
Journal Article -
8
Antithrombin Replacement and Extracorporeal Membrane Oxygenation: The time is ripe for a Simpler Solution
Published in ASAIO journal (1992) (01-10-2022)Get full text
Journal Article -
9
Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation
Published in Pharmacotherapy (01-01-2020)“…Drug pharmacokinetics may be significantly altered in patients receiving extracorporeal membrane oxygenation (ECMO). Ensuring the optimized effective dosing of…”
Get full text
Journal Article -
10
Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation
Published in Critical care medicine (01-05-2023)“…To assess the wholistic costs of systemic anticoagulation delivery in heparin versus bivalirudin-based maintenance of adult patients supported on…”
Get full text
Journal Article -
11
Bivalirudin Superiority in Pediatric Berlin Hearts: Too Early to Draw Conclusions?
Published in ASAIO journal (1992) (01-11-2023)Get full text
Journal Article -
12
The use of flumazenil for benzodiazepine associated respiratory depression in postanesthesia recovery: risks and outcomes
Published in Brazilian journal of anesthesiology (Elsevier) (01-07-2018)“…The primary aim was to determine risk factors for flumazenil administration during postanesthesia recovery. A secondary aim was to describe outcomes among…”
Get full text
Journal Article -
13
-
14
Elevated Serum Cobalt Concentrations Associated With Hydroxocobalamin Administration for Refractory Vasoplegia
Published in Journal of cardiothoracic and vascular anesthesia (01-12-2019)Get full text
Journal Article -
15
Refractory Hypotension During ECMO: Words of Caution When Using Methylene Blue
Published in Journal of cardiothoracic and vascular anesthesia (01-02-2022)Get full text
Journal Article -
16
Bivalirudin or heparin for systemic anticoagulation during pediatric extracorporeal membrane oxygenation: Multicenter retrospective study
Published in Thrombosis research (01-09-2023)“…The objective of this study is to evaluate the outcomes of unfractionated heparin (UFH) compared to bivalirudin anticoagulation in pediatric ExtraCorporeal…”
Get full text
Journal Article -
17
Cumulative epinephrine dose during cardiac arrest and neurologic outcome after extracorporeal cardiopulmonary resuscitation
Published in The American journal of emergency medicine (01-06-2024)“…Epinephrine is recommended without an apparent ceiling dosage during cardiac arrest. However, excessive alpha- and beta-adrenergic stimulation may contribute…”
Get full text
Journal Article -
18
Use of ecarin chromogenic assay during bivalirudin anticoagulation in adult extracorporeal membrane oxygenation
Published in Thrombosis research (01-08-2023)“…•The aPTT lacks specificity for bivalirudin and may be unreliable during ECMO.•Ecarin chromogenic assay (ECA) was evaluated for bivalirudin monitoring during…”
Get full text
Journal Article -
19
The Year in Extracorporeal Membrane Oxygenation: Selected Highlights From 2021
Published in Journal of cardiothoracic and vascular anesthesia (01-07-2022)“…This review summarizes the extracorporeal membrane oxygenation (ECMO) or extracorporeal life support literature published in 2021. This Selected Highlights…”
Get full text
Journal Article -
20
Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery
Published in Heart & lung (01-03-2021)“…•Hydroxocobolamine (HCB) 5 g used increasingly for refractory vasodilatory shock.•Study of HCB administered to 12 patients over a median duration of 6 h.•Mean…”
Get full text
Journal Article